Views | |
---|---|
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177 Lu-labeled prostate-specific membrane antigen | 115 |
March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
---|---|---|---|---|---|---|---|
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177 Lu-labeled prostate-specific membrane antigen | 6 | 1 | 0 | 3 | 3 | 1 | 1 |
Views | |
---|---|
2020_Huang_etal.pdf | 57 |